David A. Siegel Zim Vie Inc. Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Zim Vie Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 14,400 shares of ZIMV stock, worth $273,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,400

Previous 12,600 14.29%

Holding current value

$273,312

Previous $136,000 1.47%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.28 - $10.56 $14,903 - $19,008	1,800 Added 14.29%	14,400 $134,000
Q1 2025 May 15, 2025	SELL	$10.8 - $15.22 $2,160 - $3,044	-200 Reduced 1.56%	12,600 $136,000
Q4 2024 Feb 14, 2025	SELL	$13.21 - $16.0 $42,272 - $51,200	-3,200 Reduced 20.0%	12,800 $179,000
Q3 2024 Nov 14, 2024	SELL	$15.43 - $21.95 $456,728 - $649,720	-29,600 Reduced 64.91%	16,000 $253,000
Q2 2024 Aug 14, 2024	SELL	$14.79 - $18.47 $451,095 - $563,335	-30,500 Reduced 40.08%	45,600 $832,000
Q1 2024 May 15, 2024	SELL	$15.92 - $20.69 $383,672 - $498,629	-24,100 Reduced 24.05%	76,100 $1.25 Million
Q4 2023 Feb 14, 2024	BUY	$6.73 - $18.28 $91,528 - $248,608	13,600 Added 15.7%	100,200 $1.78 Million
Q3 2023 Nov 14, 2023	SELL	$9.2 - $14.12 $320,160 - $491,376	-34,800 Reduced 28.67%	86,600 $814,000
Q2 2023 Aug 14, 2023	BUY	$7.21 - $12.14 $656,831 - $1.11 Million	91,100 Added 300.66%	121,400 $1.36 Million
Q1 2023 May 15, 2023	BUY	$5.31 - $11.98 $71,685 - $161,730	13,500 Added 80.36%	30,300 $219,000
Q4 2022 Feb 14, 2023	BUY	$6.86 - $10.65 $30,870 - $47,925	4,500 Added 36.59%	16,800 $156,000
Q3 2022 Nov 14, 2022	BUY	$9.37 - $19.88 $115,250 - $244,524	12,300 New	12,300 $121,000

Others Institutions Holding ZIMV

# of Institutions

286

Shares Held

25.7M

Call Options Held

18.7K

Put Options Held

500

View Full List

About ZimVie Inc.

Ticker ZIMV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,084,000
Market Cap $495M
Description
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bo...

More about ZIMV

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account